Delivery Order SPE2DB22D3016-SPE2DB25FBJN1
Award Date 9/16/25
Potential Completion Date 10/7/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $15,151.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 280 mg tablets (28 count) on June 6, 2025, with completion targeted for June 30, 2025. This non-competitive, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count) with a ceiling value of $76,839.82. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count units) valued at $53,030.25 with a firm fixed price structure. The order is scheduled for completion by September 9, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded contract and is issued under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of IMBRUVICA 420 mg tablets (28-count packages) with a ceiling value of $15,151.52. This is a firm fixed-price delivery order with an ultimate completion date of October 1, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Imbruvica 420 mg tablets (28-count packaging) with a contract value of $7,575.75 and completion date of September 26, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for 28 tablets of Imbruvica 420 mg on September 11, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on September 16, 2025, for the supply of Imbruvica 420 mg tablets (quantity: 28 units) with a firm fixed price ceiling value of $7,575.75. The delivery order is scheduled for completion by October 7, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Imbruvica 420 mg tablets (28-count packages) under a firm fixed-price contract valued at $22,727.25. This is a non-set-aside competitive award with a completion deadline of June 17, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical prime vendor contract vehicle. The place of performance is listed as the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of IMBRUVICA 140 mg capsules (90-count units) with a ceiling value of $16,233.74. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 10, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Imbruvica 140mg (90-count units) with a ceiling value of $16,233.76 under a firm fixed-price contract type. The contract has an ultimate completion date of September 2, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with the place...